Gika, H
Following the FDA's proposed ban on 503B bulk compounding of GLP-1s in April 2026, patient-specific compounding through licensed 503A pharmacies remains the legally compliant pathway
Most peptide therapies are not covered by insurance as they are compounded medications used off-label
Whether you prefer a relaxing in-clinic experience or the convenience of mobile IV therapy at home, in your office, or at your hotel, our team ensures professional care and comfort
Before I started, I was overweight, groggy, and honestly just depressed
"A week later, my throat started to close up - I literally couldn't breathe." The 19-year-old, from Stockton-on-Tees, Durham, needed hospital treatment and was diagnosed with a serious throat and sinus infection